AU3133399A - The use of polyamines in the treatment of dermatological symptoms - Google Patents

The use of polyamines in the treatment of dermatological symptoms Download PDF

Info

Publication number
AU3133399A
AU3133399A AU31333/99A AU3133399A AU3133399A AU 3133399 A AU3133399 A AU 3133399A AU 31333/99 A AU31333/99 A AU 31333/99A AU 3133399 A AU3133399 A AU 3133399A AU 3133399 A AU3133399 A AU 3133399A
Authority
AU
Australia
Prior art keywords
skin
treatment
pruritus
polyamines
putrescine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31333/99A
Other languages
English (en)
Inventor
Theodore Toney Ilenchuk
William Stuart Maddin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU3133399A publication Critical patent/AU3133399A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU31333/99A 1998-04-03 1999-04-06 The use of polyamines in the treatment of dermatological symptoms Abandoned AU3133399A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2234196 1998-04-03
CA2234196 1998-04-03
PCT/CA1999/000285 WO1999051213A2 (fr) 1998-04-03 1999-04-06 Utilisation de polyamines dans le traitement de symptomes dermatologiques

Publications (1)

Publication Number Publication Date
AU3133399A true AU3133399A (en) 1999-10-25

Family

ID=4162303

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31333/99A Abandoned AU3133399A (en) 1998-04-03 1999-04-06 The use of polyamines in the treatment of dermatological symptoms

Country Status (6)

Country Link
EP (1) EP1075254A2 (fr)
JP (1) JP2002510618A (fr)
AU (1) AU3133399A (fr)
IL (1) IL138732A0 (fr)
MX (1) MXPA00009705A (fr)
WO (1) WO1999051213A2 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003013245A1 (fr) 2001-08-07 2003-02-20 Wisconsin Alumni Research Foundation Polyamines et analogues assurant une protection des cellules a l'occasion des chimiotherapies et radiotherapies anticancereuses
DE10219644A1 (de) * 2002-05-02 2003-11-20 Johannes Wohlrab Verwendung vom Agmatin zur topischen Applikation
US7652039B2 (en) 2002-05-17 2010-01-26 Sequella, Inc. Methods of use and compositions for the diagnosis and treatment of infectious disease
US20040033986A1 (en) 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
US7456222B2 (en) 2002-05-17 2008-11-25 Sequella, Inc. Anti tubercular drug: compositions and methods
WO2004073701A1 (fr) * 2003-02-19 2004-09-02 Kuniyasu Soda Inhibiteurs de lfa-1 et leur utilisation
ITMI20031570A1 (it) * 2003-07-31 2005-02-01 Giuliani Spa Composizione per uso dietetico, farmaceutico o cosmetico
EP1670314A4 (fr) 2003-09-05 2009-02-25 Sequella Inc Procedes et compositions renfermant des diamines comme nouveaux produits therapeutiques antituberculeux
EP1765272B1 (fr) * 2004-06-14 2009-12-16 Unilever PLC Procede de diminution de la fabrication de sebum et du diametre des pores
US20060193814A1 (en) 2005-02-25 2006-08-31 Eduardo Ruvolo Compositions for the treatment of signs of aging
US8278359B2 (en) 2005-02-25 2012-10-02 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof to treat acne or reduce the appearance of oil or pores on the skin
US8221046B2 (en) 2005-02-25 2012-07-17 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof
JP2008156330A (ja) * 2006-04-26 2008-07-10 Toyobo Co Ltd 賦活化剤及び抗老化剤
WO2008051080A1 (fr) * 2006-10-25 2008-05-02 Fridtjof Bjerke Crème pour l'épiderme comprenant une combinaison d'aloès officinal et de spermine
WO2008113364A2 (fr) * 2007-03-20 2008-09-25 Recepticon Aps Prévention de la néphrotoxicité iii
CA2706630A1 (fr) * 2007-11-27 2009-06-04 Kenneth Nicholis Dolynchuk Utilisation d'un inhibiteur de transglutaminase pour le traitement de la peau
DK2898881T3 (en) * 2010-08-04 2019-02-04 Pierrel Pharma S R L COMPOSITIONS COMPREHENSIVE SUPRAMOLECULAR COMPLEXES OF POLYANIONIC POLYMERS AND SPERMIDINE FOR USE IN TREATMENT OF THE PERIODONTY AND DAMAGED ORAL TISSUE.
EP2600858A4 (fr) * 2010-08-04 2014-03-05 Tixupharma Complexes supramoléculaires de polymères polyanioniques et de spermidine utilisés dans l'entretien et la réparation tissulaire
KR101420267B1 (ko) 2011-10-10 2014-07-17 대구대학교 산학협력단 폴리아민을 유효성분으로 함유하는 염증의 예방 및 치료용 약학 조성물
ITMI20120363A1 (it) * 2012-03-08 2013-09-09 Carlo Angelo Ghisalberti Composizioni per il trattamento della vulvodinia
WO2018059214A1 (fr) 2016-09-29 2018-04-05 广州君赫生物科技有限公司 Composés affectant la synthèse de saicar, et applications
US20190298688A1 (en) * 2016-11-21 2019-10-03 Vivier Canada Inc. Putrescine slow-release topical formulations
WO2018126321A1 (fr) * 2017-01-06 2018-07-12 Vivier Canada Inc. Formulation de barrière topique à base de putrescine
EP3613731A4 (fr) * 2017-04-20 2021-01-13 Geneheal Biotechnology Co., Ltd. Applications de la spermidine et de son dérivé
JP6810814B2 (ja) 2017-04-20 2021-01-06 広州君赫生物科技有限公司 抗腫瘍薬の調製におけるスペルミン及びその誘導体の使用
CN111479798B (zh) 2018-05-04 2024-11-01 奥法兰股份公司 三亚乙基四胺四盐酸盐的晶形及其医药用途
US20210212964A1 (en) * 2018-06-08 2021-07-15 Vivier Canada Inc. Sterile topical saline putrescine formulation and uses thereof
CA3126875A1 (fr) 2019-02-12 2020-08-20 Vivier Canada Inc. Compositions topiques a forte concentration de vitamine c et leur procede de fabrication
JP7411983B2 (ja) * 2019-08-27 2024-01-12 国立研究開発法人物質・材料研究機構 抗炎症剤、プレフィルドシリンジ、及び、キット
JP7600521B2 (ja) * 2019-11-12 2024-12-17 東洋紡株式会社 抗炎症剤
WO2023182342A1 (fr) * 2022-03-22 2023-09-28 佐藤製薬株式会社 Agent de renforcement du muscle squelettique

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061775A (en) * 1975-09-02 1977-12-06 Merck & Co., Inc. Polyamine compounds as antibacterial agents
US4112067A (en) * 1977-02-17 1978-09-05 The Dow Chemical Company Method for treating poison ivy dermatitis using certain polyamines and polytertiaryamides
US4507321A (en) * 1982-02-17 1985-03-26 The Research Foundation Of State University Of New York Epithelial cell growth regulating composition containing polyamines and a method of using same
EP0378146B1 (fr) * 1989-01-10 1995-03-29 Merrell Pharmaceuticals Inc. Dérivés de polyamine comme agents antinéoplastiques
ATE218330T1 (de) * 1992-03-23 2002-06-15 Univ Manitoba Verwendung von transglutaminasehemmer zur behandlung des narbegewebes
EP0806947A4 (fr) * 1995-02-03 1998-10-14 Cosmederm Technologies Formulations et procedes permettant de reduire l'irritation cutanee
EP0884046A1 (fr) * 1997-05-30 1998-12-16 Sara Lee/DE N.V. Composition cosmétique à propriétés photoprotectrices

Also Published As

Publication number Publication date
JP2002510618A (ja) 2002-04-09
WO1999051213A2 (fr) 1999-10-14
WO1999051213A3 (fr) 1999-12-23
MXPA00009705A (es) 2003-07-14
IL138732A0 (en) 2001-10-31
EP1075254A2 (fr) 2001-02-14

Similar Documents

Publication Publication Date Title
WO1999051213A2 (fr) Utilisation de polyamines dans le traitement de symptomes dermatologiques
US6060474A (en) Method for preventing scar tissue formation
JP2003519187A (ja) 癌管理のための電子活性化合物の使用方法
US4797392A (en) Use of anorectal compositions
CN100420439C (zh) 双胍衍生物在制备具有瘢痕形成作用的医药产品中的应用
JPS60100517A (ja) 放射線潰瘍治療剤および方法
US20120171275A1 (en) Local administration of gallium compositions to treat pain
US10369170B1 (en) Methods of treating basal cell carcinoma and glioblastoma
US20060105057A1 (en) Compositions using tetrasilver tetroxide and methods for management of skin conditions using same
US20060240118A1 (en) Pharmacologically active strong acid solutions
JP2024055895A (ja) 基底細胞がんおよび神経膠芽腫を治療する方法
JP3084090B2 (ja) 抗プラスミン剤
CA2326614A1 (fr) Utilisation de polyamines dans le traitement de symptomes dermatologiques
CN107596370A (zh) 一种治疗宫颈糜烂的药物复方制剂及用途
US20040022868A1 (en) Compositions using tetrasilver tetroxide and methods for management of skin conditions using same
WO2017043350A1 (fr) Agent anti-démangeaison
JP2024128672A (ja) 顔の皮膚状態の改善剤
Jain et al. Episiotomy Wound Healing and Pain Management in Ayurveda: A Case Study
AU2012227281A1 (en) Composition for detection and/or treatment of lesions & Tumours
KR20020035131A (ko) 덱스라족산의 건선 치료 용도
Bendre EFFECT OF AYURVEDIC MANAGEMENT AS SUPPLEMENTARY MEDICINE IN AN INFECTED EPISIOTOMY WOUND IN AN HIV POSITIVE PATIENT: A CASE STUDY
JP2006521298A (ja) 物理的又は化学的因子により生じる非特異的炎症の治療及び抑制におけるｎ‐アセチル‐ｄ‐グルコサミンの使用
Yue-chen et al. Observations on effects of ciclopirox olamine on dermatophytosis
WO2003018036A1 (fr) Composition permettant de detecter et/ou traiter des lesions et des tumeurs
AU2002322182A1 (en) Composition for detection and/or treatment of lesions & tumors

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted